Results 261 to 268 of about 307,180 (268)

Tissue Distribution of the Death Ligand TRAIL and Its Receptors

Journal of Histochemistry and Cytochemistry, 2004
Steven De Jong, E Vellenga, Jelle Wesseling   +2 more
exaly  

Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications

Drug Resistance Updates, 2004
Sharmila Shankar, Rakesh Srivastava
exaly  

Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan

Cell Death and Differentiation, 2000
Henning Walczak, Gerharz C D, Krieg A
exaly  

TRAIL and cancer therapy

Cancer Letters, 2008
Frank Kruyt
exaly  

Happy Trails

IEEE Multimedia, 2006
openaire   +1 more source

TRAIL as a target in anti-cancer therapy

Cancer Letters, 2009
Gen Sheng Wu
exaly  

Follow the trail: Using insights from the growth of palliative care to propose a roadmap for cancer rehabilitation

Ca-A Cancer Journal for Clinicians, 2019
, Catherine Alfano, Mackenzi Pergolotti   +2 more
exaly  

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs

Cell Death and Differentiation, 2004
Andreas Krueger, Martin R Sprick, Henning Walczak   +2 more
exaly